DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models Dec. 20, 2021 No Comments
Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies Dec. 20, 2021 No Comments
ELU-001 shows efficacy and safety in preclinical models of FRalpha-overexpressing cancers Dec. 17, 2021 No Comments
3SBio's Sunshine Guojian subsidiary to develop Numab's NM-28 in Greater China area Dec. 14, 2021 No Comments
Nanjing Legend Biotechnology describes new simian ICP47-based therapeutic cells Dec. 14, 2021 No Comments
Shanghai Longwood Biopharmaceuticals synthesizes PD-1/PD-L1 interaction inhibitors Dec. 14, 2021 No Comments
Biosion licenses BSI-04702 to OBI Pharma to develop next-generation biologics Dec. 13, 2021 No Comments
RSS